Accepts insurance
Listing updated Oct 2, 2026
Retatrutide in Garner, NC: status & local weight-loss providers
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
Phase 3 complete · Not FDA-approvedRetatrutide: Phase 3 complete · FDA submission planned Q1 2027 · Not available outside trials / expanded access. Tracker
2
tracked providers
1
have 100+ Google reviews
Concierge MedSpa NC: Aesthetic & Wellness
119 Commerce Parkway · Garner, NC 27529
5.0(82 Google reviews · 6 in past year)
Accepts insurance3 reviews mention GLP-1
Listing updated Oct 2, 2026
Pins reflect street addresses where available; others are approximate (ZIP-level).
Get retatrutide updates for Garner
Nearby markets
Learn about retatrutide
Frequently asked questions
Can I get retatrutide in Garner today?
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Garner or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
What do the providers listed for Garner actually offer?
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Does being listed mean a Garner provider will prescribe retatrutide?
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
How do I hear when availability changes near Garner?
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.